What is NDC 63833-925?

63833-925 is the product NDC for Andembry (garadacimab), Garadacimab 200 mg/1.2mL injection, solution, listed with the FDA by CSL. It has 1 package NDC, shown above in 10- and 11-digit form.

CSL, NDC labeler code 63833. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Andembry?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Andembry NDC 63833-925 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)63833-925Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63833-0925Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
63833-925-01	63833092501	1 SYRINGE, GLASS in 1 CARTON (63833-925-01) / 1.2 mL in 1 SYRINGE, GLASS (63833-925-20)Marketed from Jun 16, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Andembry
Generic name (nonproprietary): garadacimab
Active ingredients: Garadacimab — 200 mg/1.2mL
Dosage form: Injection, Solution
Route: Subcutaneous
Labeler: CSLNDC labeler code 63833
Product type: Prescription drug
Marketing category: BLA — Biologics License ApplicationApplication BLA 761367
Marketing start: Jun 16, 2025
Listing expires: Dec 31, 2026
Identifiers: Product ID 63833-925_a15c0e04-117a-434d-8b34-b664701b787fSPL ID a15c0e04-117a-434d-8b34-b664701b787fSPL set ID 07b0b671-db81-49f0-a402-0c0219db7fa2RxCUI 2717175, 2717182UNII 32W6AJL0DY

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N463833092501 followed by a unit qualifier and the quantity

Package 63833-0925-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 30, 2025.

Indications (excerpt from the label)

ANDEMBRY is indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older. ANDEMBRY is an activated Factor XII (FXIIa) inhibitor (monoclonal antibody) indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 63833-925

What is NDC 63833-925?: 63833-925 is the product NDC for Andembry (garadacimab), Garadacimab 200 mg/1.2mL injection, solution, listed with the FDA by CSL. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Andembry (Garadacimab).
What is the active ingredient?: Garadacimab.
Who is the labeler?: CSL, NDC labeler code 63833. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Andembry?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Andembry (Garadacimab) NDC 63833-925